title: Neurologic assessment after fibrinolytic therapy for myocardial infarction.
authors.affiliation: Nerancy Neuroscience Intensive Care Unit, University of Virginia Health System, Charlottesville, VA 22908, USA. sdm4e@virginia.edu
authors.forename: Dea
authors.initials: D
authors.lastname: Mahanes
mesh_terms: D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D009460:Neurologic Examination / Q000451:nursing*; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D020521:Stroke / Q000139:chemically induced; D000077785:Tenecteplase; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D000077785:Tenecteplase